Literature DB >> 7869309

Response to treatment as a predictor of longterm outcome in patients with lupus nephritis.

L Fraenkel1, T MacKenzie, L Joseph, M Kashgarian, J P Hayslett, J M Esdaile.   

Abstract

OBJECTIVE: To evaluate response to therapy over one year as a predictor of several longterm outcomes in lupus nephritis.
METHODS: Response to treatment was evaluated by comparing serum creatinine and 24 h urine protein excretion at initial renal biopsy to those obtained after one year of treatment. Response at one year was evaluated as a predictor of renal failure, death due to lupus nephritis, and total lupus mortality, using survival analysis.
RESULTS: Eighty-five patients with lupus nephritis diagnosed between 1967 and 1983 and followed through 1990 were studied. Change in proteinuria was a powerful predictor of renal failure (p = 0.001) death due to lupus nephritis (p < 0.001) and overall lupus mortality (p = 0.001). In contrast to a recent study of patients selected for severe lupus nephritis, serum creatinine was not found to be of prognostic significance.
CONCLUSION: Response of proteinuria to treatment over one year is a useful predictor of longterm outcomes in lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7869309

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  Predictive factors for low rate of remission in a population of Colombian patients with severe proliferative lupus nephritis.

Authors:  Luis Fernando Pinto-Peñaranda; Vladimir Duque-Caballero; Javier Darío Márquez-Hernández; Carolina Muñoz-Grajales; Carlos Jaime Velásquez-Franco
Journal:  Clin Rheumatol       Date:  2015-01-17       Impact factor: 2.980

2.  Urinary N-acetyl-beta-D-glucosaminidase (NAG) in lupus nephritis and rheumatoid arthritis.

Authors:  Dilek Erdener; Kenan Aksu; Ilhan Biçer; Eker Doğanavşargil; Fatma Z Kutay
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

3.  Value of a complete or partial remission in severe lupus nephritis.

Authors:  Yiann E Chen; Stephen M Korbet; Robert S Katz; Melvin M Schwartz; Edmund J Lewis
Journal:  Clin J Am Soc Nephrol       Date:  2007-11-14       Impact factor: 8.237

4.  Random spot urine protein/creatinine ratio: a reliable method for monitoring lupus nephritis?

Authors:  Maria Guedes Marques; Patrícia Cotovio; Francisco Ferrer; Cristina Silva; Carlos Botelho; Karina Lopes; Pedro Maia; Armando Carreira; Mário Campos
Journal:  Clin Kidney J       Date:  2013-09-30

5.  Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome.

Authors:  Maria Dall'Era; Victoria Levesque; Neil Solomons; Matt Truman; David Wofsy
Journal:  Lupus Sci Med       Date:  2015-05-20

6.  The Impact of Baseline Serum Creatinine on Complete Remission Rate and Long-Term Outcome in Patients with Severe Lupus Nephritis.

Authors:  Stephen M Korbet; William L Whittier; Edmund J Lewis
Journal:  Nephron Extra       Date:  2016-08-18

7.  Clinicopathological findings, treatment response and predictors of long-term outcome in a cohort of lupus nephritis patients managed according to the Euro-lupus regime: a retrospective analysis in Sri Lanka.

Authors:  Nalaka Herath; Neelakanthi Ratnatunga; Kosala Weerakoon; Abdul Wazil; Nishantha Nanayakkara
Journal:  BMC Res Notes       Date:  2017-02-02

Review 8.  B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design.

Authors:  Venkat Reddy; David Jayne; David Close; David Isenberg
Journal:  Arthritis Res Ther       Date:  2013-02-11       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.